RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 Elinogrel, a Reversible Platelet Inhibitor, Shows Promising Antiplatelet Activity in Nonurgent PCI
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 8
SP 21
OP 21
DO 10.1177/155989771008017
UL http://mdc.sagepub.com/content/10/8/21.1.abstract
AB The Novel Antiplatelet Therapy in Patients Undergoing Nonurgent Percutaneous Coronary Interventions [INNOVATE PCI] trial compared with clopidogrel and elinogrel for platelet inhibition without increasing bleeding risk in patients who were undergoing elective percutaneous coronary intervention.